Eloxx Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $-4.7M | $-4.7M | $1.1K | $386.6K |
| FY2011 | $-5.4M | $-5.4M | $2.0K | $750.4K |
| FY2012 | $-4.4M | $-4.4M | $4.5K | $766.0K |
| FY2013 | $-3.9M | $-3.9M | $1.3K | $724.7K |
| FY2014 | $-4.9M | $-4.9M | $3.2K | $1.3M |
| FY2015 | $-7.3M | $-5.7M | $122.6K | $92.0K |
| FY2016 | $-3.7M | $-8.9M | $0 | $78.0K |
| FY2017 | $-1.9M | $-16.2M | $2.5K | $101.0K |
| FY2018 | $-31.4M | $-31.6M | $235.0K | $13.4M |
| FY2019 | $-39.4M | $-39.4M | $40.0K | $11.3M |
| FY2020 | $-28.2M | $-28.2M | — | $8.7M |
| FY2021 | $-35.0M | $-35.1M | $89.0K | $9.2M |
| FY2022 | $-31.8M | $-31.9M | $66.0K | $3.0M |
| FY2023 | $-14.3M | $-14.3M | — | $2.0M |
| FY2024 | $-4.7M | $-4.7M | — | $541.0K |
| FY2025 | $-6.3M | $-6.3M | — | $235.0K |